EUVIMEDOdkrijte EUVIMED
EUVIMED · CrossrefJournal

Blood Advances

ISSN 2473-9529 · American Society of Hematology

Latest articles

  1. Survival improvement of patients with DLBCL treated with third-line and beyond in the recent era in the Czech Republic

    Prokop Vodička, Andrea Janíková, Kamila Polgárová, Juraj Ďuraš, Alice Sýkorová, František Folber, Kateřina Steinerová, Heidi Móciková, Vít Procházka, Kateřina Benešová, David Belada, Michal Kaščák, Jiří Šrámek, Flóra Benkő, Jan Kořen, Vít Campr, Jan Galko, Jitka Dlouhá, Petra Blahovcová, Robert Pytlík, Marek Trněný

    Published: 2026-11-24DOI: 10.1182/bloodadvances.2026020000

  2. Interindividual HLA evolutionary divergence in mismatched unrelated donor allo-HCT for malignant hematological disorders

    Simona Pagliuca, Jarl E. Mooyaart, Francis Ayuk, Robert Zeiser, Victoria Potter, Peter Dreger, Wolfgang Bethge, Inken Hilgendorf, David Michonneau, Alessandro Rambaldi, Henrik Sengeloev, Jakob Passweg, Deborah Richardson, Tobias Gedde-Dahl, Francesca Kinsella, Matthias Edinger, Stephan Mielke, Matthias Eder, Marco Andreani, Pietro Crivello, Pietro Merli, Jorinde D. Hoogenboom, Liesbeth C. de Wreede, Christian Chabannon, Jürgen Kuball, Carmelo Gurnari, Katharina Fleischhauer, Annalisa Ruggeri, Tobias L. Lenz

    Published: 2026-11-24DOI: 10.1182/bloodadvances.2026020341

  3. Teclistamab and daratumumab immune-based doublet therapy for relapsed/refractory multiple myeloma: the TRIMM-2 study

    Paula Rodríguez-Otero, Daniel Morillo, Anita D’Souza, Donna Reece, Niels W. C. J. van de Donk, Ajai Chari, Bhagirathbhai Dholaria, K. Martin Kortüm, María-Victoria Mateos, John T. McKay, Laura Rosiñol, Anna Sureda Balari, Ralph Wäsch, Manisha Bhutani, Katja Weisel, Nizar Bahlis, Deeksha Vishwamitra, Sheri Skerget, Kalpana Bakshi, Yue Guo, Weili Sun, Jenna D. Goldberg, Tara Stephenson, Thomas J. Prior, Lien Vandenberk, Sangmin Lee, M. Damiette Smit, Raluca I. Verona, Albert Oriol, Amrita Krishnan

    Published: 2026-11-24DOI: 10.1182/bloodadvances.2026020648

  4. Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis

    Evgenii Shumilov, Lina Kolloch, Philipp Faustmann, Débora-Michèle Grote Urtubey, Marcel Teichert, Joseph Kauer, Meng Wang, Maximilian Seib, Friedrich-Linus Rößiger, Rebecca Wurm-Kuczera, Tobias Tix, Micha Peeck, Mathias Hänel, Alexander Hölscher, Stephan de Bra, Philipp Gödel, Zoi Saxonis, Belana Kuhn, Vanja Zeremski, Susanne Ghandili, Franziska Brunner, Enver Aydilek, Markus Maulhardt, Stephanie Mayer, Philipp Nakov, Christoph Brey, Friedrich Gregor, Christian Schultze-Florey, Giuliano Filippini Velazquez, Paolo Mazzeo, Igor Kos, Anna Ossami Saidy, Christoph Kimmich, Maika Klaiber-Hakimi, Philipp Berning, Andrea Kerkhoff, Bertram Glass, Isabelle Krämer, Lorenz Thurner, Mathias Lutz

    Published: 2026-11-24DOI: 10.1182/bloodadvances.2026020742

  5. Impact of cytoreductive therapy in myeloproliferative neoplasm–associated splanchnic vein thrombosis

    Douglas Tremblay, Amica Ko, Pavlina Chrysafi, Joan How, Rebecca Zon, Damon Houghton, Atefeh Ghorbanzadeh, Dahniel Sastow, Sai Swetha Alladi, Maria Georgen, Abi Prabhu, Vrushali Pachpande, Sai Sudha Valisekka, Balkrishna Jahagirdar, Sargam Kapoor, Andrew Peseski, Radhika Gangaraju, Ruchi Desai, Guoliang Zheng, Shreyash Dalmia, Vinai Bhagirath, Alejandro Godoy, Alessandra Iurlo, Daniele Cattaneo, Paola Guglielmelli, Alessandro Vannucchi, Valentina Boldrini, Valerio De Stefano, Silvia Betti, Elena Rossi, Walter Ageno, Jonathan Berry, Margherita Maffioli, Mukul Aggarwal, Amiya Ranjan Nayak, Rishi Dhawan, Thita Chiasakul, Kristen Sanfilippo, Gabriela S. Hobbs, John Mascarenhas

    Published: 2026-11-24DOI: 10.1182/bloodadvances.2026020925

  6. Outcomes after 7/8 and <7/8 mismatched unrelated donor PBSC transplantation with PTCy: results from the ACCESS trial

    Antonio Martin Jimenez Jimenez, Joseph Stanek, Brent R. Logan, Erin Leckrone, Heather E. Stefanski, Jeffery J. Auletta, Stephen R. Spellman, Craig Malmberg, Medhat Askar, Rachel Cusatis, Brian C. Shaffer, Dipenkumar Modi, Farhad Khimani, Mahasweta Gooptu, Mehdi Hamadani, Martin Maiers, Stephanie Bo-Subait, Javier Bolaños-Meade, Uttam Rao, Jordan Milner, Ramzi Abboud, Katarzyna Jamieson, George Carrum, Bhagirathbhai Dholaria, William J. Hogan, Ran Reshef, Satyajit Kosuri, Rachel Cook, Karen Ballen, Alison Loren, Karilyn Larkin, Sally Arai, Muna Qayed, Sung Won Choi, Larisa Broglie, Bronwen E. Shaw, Steven M. Devine, Monzr M. Al Malki

    Published: 2026-11-24DOI: 10.1182/bloodadvances.2026021081

  7. Relationship between salvage strategy and outcomes in patients with CBF or NPM1 -mutated AML and first molecular relapse

    Corentin Orvain, Jules Higué, Pierre Peterlin, Pierre-Yves Dumas, Yohan Desbrosses, Marie-Anne Hospital, Emmanuelle Tavernier, Martin Carré, Sabrina Barrière, Audrey Couturier, Thomas Cluzeau, Areti Chantzi, Gaspar Aspas Requena, Laetitia Largeaud, Anne Bouvier, Audrey Bidet, Florian Renosi, Anne-Sophie Alary, Pascale Flandrin-Gresta, Sylvie Tondeur, Lauren Véronèse, Cédric Pastoret, Bérengère Dadone-Montaudié, Sébastien Lachot, Sarah Bertoli, Patrice Chevallier, Mathilde Hunault, Arnaud Pigneux, Christian Récher

    Published: 2026-11-24DOI: 10.1182/bloodadvances.2026021088

  8. Diagnostic accuracy of fat pad sampling and bone marrow biopsy for AL amyloidosis: a systematic review and meta-analysis

    Muayad Azzam, Hassan Kawtharany, Jamil Nazzal, Qais Hamarsha, Aseel Alkhader, Tala Khraise, Mohammad Mahmoud AlMasri, Hadi Khaled Abou Zeid, Iktimal Alwan, Nour Jaber, Maria Adela Aguirre, Deborah Boedicker, Naresh Bumma, Antonia S. Carroll, Raymond Comenzo, Joselle Cook, Noel R. Dasgupta, Alfredo H. De La Torre, Angela Dispenzieri, Faizi Jamal, Jack Khouri, Nelson Leung, Maria M. Picken, Shahzad Raza, Vaishali Sanchorawala, Nitasha Sarswat, Hira Shaikh, Daulath Singh, Matthew D. Seftel, Vishal Kukreti, Reem A. Mustafa

    Published: 2026-11-24DOI: 10.1182/bloodadvances.2026021240

Volumes

2026 · 9662025 · 7532024 · 7072023 · 8312022 · 6822021 · 5732020 · 6752019 · 4632018 · 4042017 · 3162016 · 33

Znanje, ki ustreza vašemu delu.

Od brezplačnega začetka in osebnega iskanja literature do celotnega paketa Research Suite.

Ogled tarif →

Ali so vključena vsa polna besedila založnikov?

Ne. Bibliografski zapisi, povzetki in celotna besedila so različne vsebine. Ali je celotno besedilo na voljo, je odvisno od vira, odprtega dostopa in vaših obstoječih licenc. Paket EUVIMED ne nadomešča dodatnih pravic založnikov.